In patients with impaired renal function or fast-deteriorating eGFR at baseline, lucerastat was associated with a marked attenuation of kidney function loss, suggesting a potential disease-modifying e ...
As the new year begins, many are using glucagon-like peptide-1 receptor agonists (GLP-1RAs) for weight loss. While effective, ...
In patients with impaired renal function or fast-deteriorating eGFR at baseline, lucerastat was associated with a marked ...
After greenlighting 56 novel therapeutics in 2025, four notable applications continue to await the agency’s action after ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback